AI assistant
ANGIODYNAMICS INC — Director's Dealing 2013
Nov 5, 2013
32939_dirs_2013-11-05_117e1af6-e412-42e5-a037-f6e050b05b85.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2013-11-01
Reporting Person: DEVIVO JOSEPH (Director, President and CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-11-01 | Performance Right | $ | A | 36676 | Acquired | Common Stock (36676) | Direct |
Footnotes
F1: Each Performance Right represents a contingent right to receive one share of AngioDynamics, Inc. common stock. The target number of AngioDynamics, Inc. common stock is indicated in columns 5 and 7. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period covering AngioDynamics, Inc.'s fiscal years 2014, 2015 and 2016. A portion of the shares may be earned based on performance in each year of the performance period. Any shares that do not vest at the end of the performance period are forfeited.